ReviewExpert review of vaccines2012
Resolving pertussis immunity and vaccine effectiveness using incidence time series.
Review in Expert review of vaccines, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Delayed introduction, transmission variation and susceptible dynamics explain spatial asynchrony during Republic of Korea's large pertussis outbreak.Journal of the Royal Society, Interface · 2026Article
- Quantifying the impact of vaccination on pertussis dynamics in Sweden.PLoS computational biology · 2026Article
- Pertussis vaccines, epidemiology and evolution.Nature reviews. Microbiology · 2024Review
- Immunological heterogeneity informs estimation of the durability of vaccine protection.Journal of the Royal Society, Interface · 2022Article
- Dissecting recurrent waves of pertussis across the boroughs of London.PLoS computational biology · 2022Review
- Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.Vaccine · 2021Article
- Countering the Curse of Dimensionality: Exploring Data-generating Mechanisms Through Participant Observation and Mechanistic Modeling.Epidemiology (Cambridge, Mass.) · 2019Article
- Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models.Human vaccines & immunotherapeutics · 2019Article
- A second-order iterated smoothing algorithm.Statistics and computing · 2017Article
- Article
- Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.Parasitology · 2016Article
- The pertussis enigma: reconciling epidemiology, immunology and evolution.Proceedings. Biological sciences · 2016Review
- An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005-2011.BMC infectious diseases · 2015Article
- Demographic buffering: titrating the effects of birth rate and imperfect immunity on epidemic dynamics.Journal of the Royal Society, Interface · 2015Article
- Combating pertussis resurgence: One booster vaccination schedule does not fit all.Proceedings of the National Academy of Sciences of the United States of America · 2015Article
- Perplexities of pertussis: recent global epidemiological trends and their potential causes.Epidemiology and infection · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Resolving the long-term, population-level consequence of vaccine-induced immunity to pertussis is a key challenge for control strategies and vaccine development. Controlled vaccine efficacy studies provide invaluable information; however, they are limited in scope by their sample size and follow-up duration. Long-term time series of incidence data collected by public health institutions provide insight at a broader scale, especially when the data are spatially explicit and age stratified. By using modern ecological and statistical methodolgies, which are reviewed in this paper, new insights into the duration of transmission-blocking immunity and the age-specific patterns of transmission can be gained. Recent advances in computing power and statistical software development will increasingly make these methods available to public health practitioners, vaccine developers and academics alike.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.